Literature DB >> 29885800

Malassezia pachydermatis from animals: Planktonic and biofilm antifungal susceptibility and its virulence arsenal.

Raimunda Sâmia Nogueira Brilhante1, Maria Gleiciane da Rocha2, Glaucia Morgana de Melo Guedes3, Jonathas Sales de Oliveira3, Géssica Dos Santos Araújo2, Jaime David Acosta España3, Jamille Alencar Sales2, Lara de Aguiar2, Manoel de Araújo Neto Paiva3, Rossana de Aguiar Cordeiro3, Waldemiro de Aquino Pereira-Neto3, Adriana de Queiroz Pinheiro2, José Júlio Costa Sidrim3, Débora de Souza Collares Maia Castelo-Branco3, Marcos Fábio Gadelha Rocha4.   

Abstract

The yeast Malassezia pachydermatis is a component of the microbiota of dogs and cats, however it can cause otitis and seborrheic dermatitis in these animals. The objective of this study was to determine the antifungal susceptibility, and evaluate virulence and pathogenicity of 25 M. pachydermatis strains from animals. Susceptibility to ketoconazole, fluconazole, itraconazole, voriconazole, terbinafine, and amphotericin B was evaluated by broth microdilution assay. In addition, biofilm-forming ability, protease, phospholipase, hemolysin and melanin production and adhesion to epithelial cells by this yeast species were assessed. Finally, strain pathogenicity was investigated using the nematode Caenorhabditis elegans. Concerning the planktonic susceptibility, minimum inhibitory concentrations varied from <0.03 to>64 μg/mL for azole derivatives, 1 to >16 μg/mL for amphotericin B and 0.03 to 0.25 μg/mL for terbinafine. All strains were classified as strong biofilm producers, and ketoconazole, fluconazole and amphotericin B presented the best inhibitory effect against mature biofilms. All fungal isolates produced proteases, whereas 14/25 strains were positive for phospholipase production. Hemolytic activity was not observed and 18/25 strains showed dark pigmentation in the presence of L-DOPA. Regarding adhesion to epithelial cells, a low adhesion rate was observed in 10/12 evaluated strains. C. elegans mortality rate reached 95.9% after 96 h of exposure of the worms to M. pachydermatis. This yeast species produces important virulence factors and presents high pathogenicity, corroborating its clinical importance.
Copyright © 2018. Published by Elsevier B.V.

Entities:  

Keywords:  Antifungal susceptibility; Malassezia pachydermatis; Pathogenicity; Virulence attributes

Mesh:

Substances:

Year:  2018        PMID: 29885800     DOI: 10.1016/j.vetmic.2018.05.003

Source DB:  PubMed          Journal:  Vet Microbiol        ISSN: 0378-1135            Impact factor:   3.293


  7 in total

1.  Galleria mellonella as a Novelty in vivo Model of Host-Pathogen Interaction for Malassezia furfur CBS 1878 and Malassezia pachydermatis CBS 1879.

Authors:  Maritza Torres; Elkin Nicolás Pinzón; Flor Maria Rey; Heydys Martinez; Claudia Marcela Parra Giraldo; Adriana Marcela Celis Ramírez
Journal:  Front Cell Infect Microbiol       Date:  2020-05-05       Impact factor: 5.293

Review 2.  Malassezia Yeasts in Veterinary Dermatology: An Updated Overview.

Authors:  Jacques Guillot; Ross Bond
Journal:  Front Cell Infect Microbiol       Date:  2020-02-28       Impact factor: 5.293

3.  Pilot study of dogs with suppurative and non-suppurative Malassezia otitis: A case series.

Authors:  Tania C Nunes Rodrigues; Sophie I Vandenabeele
Journal:  BMC Vet Res       Date:  2021-11-18       Impact factor: 2.741

Review 4.  Malassezia: Zoonotic Implications, Parallels and Differences in Colonization and Disease in Humans and Animals.

Authors:  Stefan Hobi; Claudia Cafarchia; Valentina Romano; Vanessa R Barrs
Journal:  J Fungi (Basel)       Date:  2022-07-04

Review 5.  Many ways, one microorganism: Several approaches to study Malassezia in interactions with model hosts.

Authors:  Kevin Ehemann; María Juliana Mantilla; Felipe Mora-Restrepo; Andrea Rios-Navarro; Maritza Torres; Adriana Marcela Celis Ramírez
Journal:  PLoS Pathog       Date:  2022-09-08       Impact factor: 7.464

6.  New Therapeutic Candidates for the Treatment of Malassezia pachydermatis -Associated Infections.

Authors:  Angie Sastoque; Sergio Triana; Kevin Ehemann; Lina Suarez; Silvia Restrepo; Han Wösten; Hans de Cock; Miguel Fernández-Niño; Andrés Fernando González Barrios; Adriana Marcela Celis Ramírez
Journal:  Sci Rep       Date:  2020-03-17       Impact factor: 4.379

7.  The use of multicomponent ear drops in the treatment of otitis of various etiologies in animals.

Authors:  Mikhail Vladimirovich Arisov; Evgenia Nikolaevna Indyuhova; Gulnara Bakitovna Arisova
Journal:  J Adv Vet Anim Res       Date:  2020-01-25
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.